Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-16-011550
Filing Date
2016-03-24
Accepted
2016-03-24 16:31:21
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B4 a2227966z424b4.htm 424B4 1867748
2 G352599.JPG g352599.jpg GRAPHIC 20386
3 G655374.JPG g655374.jpg GRAPHIC 82784
4 G669291.JPG g669291.jpg GRAPHIC 59794
5 G762455.JPG g762455.jpg GRAPHIC 63942
6 G249161.JPG g249161.jpg GRAPHIC 27215
7 G374407.JPG g374407.jpg GRAPHIC 39576
8 G777414.JPG g777414.jpg GRAPHIC 30782
9 G585593.JPG g585593.jpg GRAPHIC 49502
10 G1036125.JPG g1036125.jpg GRAPHIC 53803
11 G417061.JPG g417061.jpg GRAPHIC 34456
12 G358026.JPG g358026.jpg GRAPHIC 47486
13 G666830.JPG g666830.jpg GRAPHIC 50197
14 G211965.JPG g211965.jpg GRAPHIC 72837
15 G666115.JPG g666115.jpg GRAPHIC 34975
  Complete submission text file 0001047469-16-011550.txt   2790404
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1214
Type: 424B4 | Act: 33 | File No.: 333-208850 | Film No.: 161527392
SIC: 2834 Pharmaceutical Preparations